カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の糖尿病治療薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Diabetic Therapeutic Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19262）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19262
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：111
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の糖尿病治療薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

糖尿病治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の糖尿病治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

糖尿病治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・インスリン療法、非インスリン療法

用途別セグメントは次のように区分されます。
・1型糖尿病、2型糖尿病、妊娠糖尿病

世界の糖尿病治療薬市場の主要な市場プレーヤーは以下のとおりです。
・AstraZeneca、Eli Lilly、Merck、Novo Nordisk、Sanofi、Pfizer、Novartis、Perle Biosciences、Sun Pharma、Takeda Pharmaceuticals、F. Hoffmann-La Roche、Belrose Pharma、Mitsubishi Tanabe Pharma、Dong-A ST、Eisai、Arbutus Biopharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、糖尿病治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な糖尿病治療薬メーカーの企業概要、2019年～2022年までの糖尿病治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な糖尿病治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別糖尿病治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの糖尿病治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での糖尿病治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および糖尿病治療薬の産業チェーンを掲載しています。
・第13、14、15章では、糖尿病治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 糖尿病治療薬の概要
- 種類別分析（2017年vs2021年vs2028年）：インスリン療法、非インスリン療法
- 用途別分析（2017年vs2021年vs2028年）：1型糖尿病、2型糖尿病、妊娠糖尿病
- 世界の糖尿病治療薬市場規模・予測
- 世界の糖尿病治療薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- AstraZeneca、Eli Lilly、Merck、Novo Nordisk、Sanofi、Pfizer、Novartis、Perle Biosciences、Sun Pharma、Takeda Pharmaceuticals、F. Hoffmann-La Roche、Belrose Pharma、Mitsubishi Tanabe Pharma、Dong-A ST、Eisai、Arbutus Biopharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：インスリン療法、非インスリン療法
・用途別分析2017年-2028年：1型糖尿病、2型糖尿病、妊娠糖尿病
・糖尿病治療薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・糖尿病治療薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・糖尿病治療薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・糖尿病治療薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・糖尿病治療薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Diabetic Therapeutic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Diabetic Therapeutic Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Type 1 Diabetes accounting for % of the Diabetic Therapeutic Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Insulin Therapies segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Diabetic Therapeutic Drugs include AstraZeneca, Eli Lilly, Merck, Novo Nordisk, and Sanofi, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Diabetic Therapeutic Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Insulin Therapies
Non-Insulin Therapies
Market segment by Application can be divided into
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
The key market players for global Diabetic Therapeutic Drugs market are listed below:
AstraZeneca
Eli Lilly
Merck
Novo Nordisk
Sanofi
Pfizer
Novartis
Perle Biosciences
Sun Pharma
Takeda Pharmaceuticals
F. Hoffmann-La Roche
Belrose Pharma
Mitsubishi Tanabe Pharma
Dong-A ST
Eisai
Arbutus Biopharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Diabetic Therapeutic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Diabetic Therapeutic Drugs, with price, sales, revenue and global market share of Diabetic Therapeutic Drugs from 2019 to 2022.
Chapter 3, the Diabetic Therapeutic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diabetic Therapeutic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Diabetic Therapeutic Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Diabetic Therapeutic Drugs.
Chapter 13, 14, and 15, to describe Diabetic Therapeutic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Diabetic Therapeutic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Diabetic Therapeutic Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Insulin Therapies
1.2.3 Non-Insulin Therapies
1.3 Market Analysis by Application
1.3.1 Overview: Global Diabetic Therapeutic Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.3.4 Gestational Diabetes
1.4 Global Diabetic Therapeutic Drugs Market Size & Forecast
1.4.1 Global Diabetic Therapeutic Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Diabetic Therapeutic Drugs Sales in Volume (2017-2028)
1.4.3 Global Diabetic Therapeutic Drugs Price (2017-2028)
1.5 Global Diabetic Therapeutic Drugs Production Capacity Analysis
1.5.1 Global Diabetic Therapeutic Drugs Total Production Capacity (2017-2028)
1.5.2 Global Diabetic Therapeutic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Diabetic Therapeutic Drugs Market Drivers
1.6.2 Diabetic Therapeutic Drugs Market Restraints
1.6.3 Diabetic Therapeutic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Diabetic Therapeutic Drugs Product and Services
2.1.4 AstraZeneca Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Diabetic Therapeutic Drugs Product and Services
2.2.4 Eli Lilly Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Diabetic Therapeutic Drugs Product and Services
2.3.4 Merck Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business
2.4.3 Novo Nordisk Diabetic Therapeutic Drugs Product and Services
2.4.4 Novo Nordisk Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Diabetic Therapeutic Drugs Product and Services
2.5.4 Sanofi Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Diabetic Therapeutic Drugs Product and Services
2.6.4 Pfizer Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Diabetic Therapeutic Drugs Product and Services
2.7.4 Novartis Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Perle Biosciences
2.8.1 Perle Biosciences Details
2.8.2 Perle Biosciences Major Business
2.8.3 Perle Biosciences Diabetic Therapeutic Drugs Product and Services
2.8.4 Perle Biosciences Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Sun Pharma
2.9.1 Sun Pharma Details
2.9.2 Sun Pharma Major Business
2.9.3 Sun Pharma Diabetic Therapeutic Drugs Product and Services
2.9.4 Sun Pharma Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Takeda Pharmaceuticals
2.10.1 Takeda Pharmaceuticals Details
2.10.2 Takeda Pharmaceuticals Major Business
2.10.3 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Product and Services
2.10.4 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 F. Hoffmann-La Roche
2.11.1 F. Hoffmann-La Roche Details
2.11.2 F. Hoffmann-La Roche Major Business
2.11.3 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Product and Services
2.11.4 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Belrose Pharma
2.12.1 Belrose Pharma Details
2.12.2 Belrose Pharma Major Business
2.12.3 Belrose Pharma Diabetic Therapeutic Drugs Product and Services
2.12.4 Belrose Pharma Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Mitsubishi Tanabe Pharma
2.13.1 Mitsubishi Tanabe Pharma Details
2.13.2 Mitsubishi Tanabe Pharma Major Business
2.13.3 Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Product and Services
2.13.4 Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Dong-A ST
2.14.1 Dong-A ST Details
2.14.2 Dong-A ST Major Business
2.14.3 Dong-A ST Diabetic Therapeutic Drugs Product and Services
2.14.4 Dong-A ST Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Eisai
2.15.1 Eisai Details
2.15.2 Eisai Major Business
2.15.3 Eisai Diabetic Therapeutic Drugs Product and Services
2.15.4 Eisai Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Arbutus Biopharma
2.16.1 Arbutus Biopharma Details
2.16.2 Arbutus Biopharma Major Business
2.16.3 Arbutus Biopharma Diabetic Therapeutic Drugs Product and Services
2.16.4 Arbutus Biopharma Diabetic Therapeutic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Diabetic Therapeutic Drugs Breakdown Data by Manufacturer
3.1 Global Diabetic Therapeutic Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Diabetic Therapeutic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Diabetic Therapeutic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Diabetic Therapeutic Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Diabetic Therapeutic Drugs Manufacturer Market Share in 2021
3.5 Global Diabetic Therapeutic Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Diabetic Therapeutic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Diabetic Therapeutic Drugs Market Size by Region
4.1.1 Global Diabetic Therapeutic Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Diabetic Therapeutic Drugs Revenue by Region (2017-2028)
4.2 North America Diabetic Therapeutic Drugs Revenue (2017-2028)
4.3 Europe Diabetic Therapeutic Drugs Revenue (2017-2028)
4.4 Asia-Pacific Diabetic Therapeutic Drugs Revenue (2017-2028)
4.5 South America Diabetic Therapeutic Drugs Revenue (2017-2028)
4.6 Middle East and Africa Diabetic Therapeutic Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Diabetic Therapeutic Drugs Sales in Volume by Type (2017-2028)
5.2 Global Diabetic Therapeutic Drugs Revenue by Type (2017-2028)
5.3 Global Diabetic Therapeutic Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Diabetic Therapeutic Drugs Sales in Volume by Application (2017-2028)
6.2 Global Diabetic Therapeutic Drugs Revenue by Application (2017-2028)
6.3 Global Diabetic Therapeutic Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Diabetic Therapeutic Drugs Sales by Type (2017-2028)
7.2 North America Diabetic Therapeutic Drugs Sales by Application (2017-2028)
7.3 North America Diabetic Therapeutic Drugs Market Size by Country
7.3.1 North America Diabetic Therapeutic Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Diabetic Therapeutic Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Diabetic Therapeutic Drugs Sales by Type (2017-2028)
8.2 Europe Diabetic Therapeutic Drugs Sales by Application (2017-2028)
8.3 Europe Diabetic Therapeutic Drugs Market Size by Country
8.3.1 Europe Diabetic Therapeutic Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Diabetic Therapeutic Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Diabetic Therapeutic Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Diabetic Therapeutic Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Diabetic Therapeutic Drugs Market Size by Region
9.3.1 Asia-Pacific Diabetic Therapeutic Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Diabetic Therapeutic Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Diabetic Therapeutic Drugs Sales by Type (2017-2028)
10.2 South America Diabetic Therapeutic Drugs Sales by Application (2017-2028)
10.3 South America Diabetic Therapeutic Drugs Market Size by Country
10.3.1 South America Diabetic Therapeutic Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Diabetic Therapeutic Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Diabetic Therapeutic Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Diabetic Therapeutic Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Diabetic Therapeutic Drugs Market Size by Country
11.3.1 Middle East & Africa Diabetic Therapeutic Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Diabetic Therapeutic Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Diabetic Therapeutic Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Diabetic Therapeutic Drugs
12.3 Diabetic Therapeutic Drugs Production Process
12.4 Diabetic Therapeutic Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Diabetic Therapeutic Drugs Typical Distributors
13.3 Diabetic Therapeutic Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Diabetic Therapeutic Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Diabetic Therapeutic Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Diabetic Therapeutic Drugs Product and Services
Table 6. AstraZeneca Diabetic Therapeutic Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly Major Business
Table 9. Eli Lilly Diabetic Therapeutic Drugs Product and Services
Table 10. Eli Lilly Diabetic Therapeutic Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Diabetic Therapeutic Drugs Product and Services
Table 14. Merck Diabetic Therapeutic Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 16. Novo Nordisk Major Business
Table 17. Novo Nordisk Diabetic Therapeutic Drugs Product and Services
Table 18. Novo Nordisk Diabetic Therapeutic Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Diabetic Therapeutic Drugs Product and Services
Table 22. Sanofi Diabetic Therapeutic Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Diabetic Therapeutic Drugs Product and Services
Table 26. Pfizer Diabetic Therapeutic Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Novartis Basic Information, Manufacturing Base and Competitors
Table 28. Novartis Major Business
Table 29. Novartis Diabetic Therapeutic Drugs Product and Services
Table 30. Novartis Diabetic Therapeutic Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Perle Biosciences Basic Information, Manufacturing Base and Competitors
Table 32. Perle Biosciences Major Business
Table 33. Perle Biosciences Diabetic Therapeutic Drugs Product and Services
Table 34. Perle Biosciences Diabetic Therapeutic Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Sun Pharma Major Business
Table 37. Sun Pharma Diabetic Therapeutic Drugs Product and Services
Table 38. Sun Pharma Diabetic Therapeutic Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Takeda Pharmaceuticals Major Business
Table 41. Takeda Pharmaceuticals Diabetic Therapeutic Drugs Product and Services
Table 42. Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 44. F. Hoffmann-La Roche Major Business
Table 45. F. Hoffmann-La Roche Diabetic Therapeutic Drugs Product and Services
Table 46. F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Belrose Pharma Basic Information, Manufacturing Base and Competitors
Table 48. Belrose Pharma Major Business
Table 49. Belrose Pharma Diabetic Therapeutic Drugs Product and Services
Table 50. Belrose Pharma Diabetic Therapeutic Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 52. Mitsubishi Tanabe Pharma Major Business
Table 53. Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Product and Services
Table 54. Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Dong-A ST Basic Information, Manufacturing Base and Competitors
Table 56. Dong-A ST Major Business
Table 57. Dong-A ST Diabetic Therapeutic Drugs Product and Services
Table 58. Dong-A ST Diabetic Therapeutic Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Eisai Basic Information, Manufacturing Base and Competitors
Table 60. Eisai Major Business
Table 61. Eisai Diabetic Therapeutic Drugs Product and Services
Table 62. Eisai Diabetic Therapeutic Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Arbutus Biopharma Basic Information, Manufacturing Base and Competitors
Table 64. Arbutus Biopharma Major Business
Table 65. Arbutus Biopharma Diabetic Therapeutic Drugs Product and Services
Table 66. Arbutus Biopharma Diabetic Therapeutic Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Diabetic Therapeutic Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 68. Global Diabetic Therapeutic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Diabetic Therapeutic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Diabetic Therapeutic Drugs Production Capacity by Company, (MT): 2020 VS 2021
Table 71. Head Office and Diabetic Therapeutic Drugs Production Site of Key Manufacturer
Table 72. Diabetic Therapeutic Drugs New Entrant and Capacity Expansion Plans
Table 73. Diabetic Therapeutic Drugs Mergers & Acquisitions in the Past Five Years
Table 74. Global Diabetic Therapeutic Drugs Sales by Region (2017-2022) & (MT)
Table 75. Global Diabetic Therapeutic Drugs Sales by Region (2023-2028) & (MT)
Table 76. Global Diabetic Therapeutic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Diabetic Therapeutic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Diabetic Therapeutic Drugs Sales by Type (2017-2022) & (MT)
Table 79. Global Diabetic Therapeutic Drugs Sales by Type (2023-2028) & (MT)
Table 80. Global Diabetic Therapeutic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 81. Global Diabetic Therapeutic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 82. Global Diabetic Therapeutic Drugs Price by Type (2017-2022) & (USD/Kg)
Table 83. Global Diabetic Therapeutic Drugs Price by Type (2023-2028) & (USD/Kg)
Table 84. Global Diabetic Therapeutic Drugs Sales by Application (2017-2022) & (MT)
Table 85. Global Diabetic Therapeutic Drugs Sales by Application (2023-2028) & (MT)
Table 86. Global Diabetic Therapeutic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Diabetic Therapeutic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Diabetic Therapeutic Drugs Price by Application (2017-2022) & (USD/Kg)
Table 89. Global Diabetic Therapeutic Drugs Price by Application (2023-2028) & (USD/Kg)
Table 90. North America Diabetic Therapeutic Drugs Sales by Country (2017-2022) & (MT)
Table 91. North America Diabetic Therapeutic Drugs Sales by Country (2023-2028) & (MT)
Table 92. North America Diabetic Therapeutic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Diabetic Therapeutic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Diabetic Therapeutic Drugs Sales by Type (2017-2022) & (MT)
Table 95. North America Diabetic Therapeutic Drugs Sales by Type (2023-2028) & (MT)
Table 96. North America Diabetic Therapeutic Drugs Sales by Application (2017-2022) & (MT)
Table 97. North America Diabetic Therapeutic Drugs Sales by Application (2023-2028) & (MT)
Table 98. Europe Diabetic Therapeutic Drugs Sales by Country (2017-2022) & (MT)
Table 99. Europe Diabetic Therapeutic Drugs Sales by Country (2023-2028) & (MT)
Table 100. Europe Diabetic Therapeutic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Diabetic Therapeutic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Diabetic Therapeutic Drugs Sales by Type (2017-2022) & (MT)
Table 103. Europe Diabetic Therapeutic Drugs Sales by Type (2023-2028) & (MT)
Table 104. Europe Diabetic Therapeutic Drugs Sales by Application (2017-2022) & (MT)
Table 105. Europe Diabetic Therapeutic Drugs Sales by Application (2023-2028) & (MT)
Table 106. Asia-Pacific Diabetic Therapeutic Drugs Sales by Region (2017-2022) & (MT)
Table 107. Asia-Pacific Diabetic Therapeutic Drugs Sales by Region (2023-2028) & (MT)
Table 108. Asia-Pacific Diabetic Therapeutic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Diabetic Therapeutic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Diabetic Therapeutic Drugs Sales by Type (2017-2022) & (MT)
Table 111. Asia-Pacific Diabetic Therapeutic Drugs Sales by Type (2023-2028) & (MT)
Table 112. Asia-Pacific Diabetic Therapeutic Drugs Sales by Application (2017-2022) & (MT)
Table 113. Asia-Pacific Diabetic Therapeutic Drugs Sales by Application (2023-2028) & (MT)
Table 114. South America Diabetic Therapeutic Drugs Sales by Country (2017-2022) & (MT)
Table 115. South America Diabetic Therapeutic Drugs Sales by Country (2023-2028) & (MT)
Table 116. South America Diabetic Therapeutic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Diabetic Therapeutic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Diabetic Therapeutic Drugs Sales by Type (2017-2022) & (MT)
Table 119. South America Diabetic Therapeutic Drugs Sales by Type (2023-2028) & (MT)
Table 120. South America Diabetic Therapeutic Drugs Sales by Application (2017-2022) & (MT)
Table 121. South America Diabetic Therapeutic Drugs Sales by Application (2023-2028) & (MT)
Table 122. Middle East & Africa Diabetic Therapeutic Drugs Sales by Region (2017-2022) & (MT)
Table 123. Middle East & Africa Diabetic Therapeutic Drugs Sales by Region (2023-2028) & (MT)
Table 124. Middle East & Africa Diabetic Therapeutic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Diabetic Therapeutic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Diabetic Therapeutic Drugs Sales by Type (2017-2022) & (MT)
Table 127. Middle East & Africa Diabetic Therapeutic Drugs Sales by Type (2023-2028) & (MT)
Table 128. Middle East & Africa Diabetic Therapeutic Drugs Sales by Application (2017-2022) & (MT)
Table 129. Middle East & Africa Diabetic Therapeutic Drugs Sales by Application (2023-2028) & (MT)
Table 130. Diabetic Therapeutic Drugs Raw Material
Table 131. Key Manufacturers of Diabetic Therapeutic Drugs Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Diabetic Therapeutic Drugs Typical Distributors
Table 135. Diabetic Therapeutic Drugs Typical Customers
List of Figures
Figure 1. Diabetic Therapeutic Drugs Picture
Figure 2. Global Diabetic Therapeutic Drugs Revenue Market Share by Type in 2021
Figure 3. Insulin Therapies
Figure 4. Non-Insulin Therapies
Figure 5. Global Diabetic Therapeutic Drugs Revenue Market Share by Application in 2021
Figure 6. Type 1 Diabetes
Figure 7. Type 2 Diabetes
Figure 8. Gestational Diabetes
Figure 9. Global Diabetic Therapeutic Drugs Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 10. Global Diabetic Therapeutic Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Diabetic Therapeutic Drugs Sales (2017-2028) & (MT)
Figure 12. Global Diabetic Therapeutic Drugs Price (2017-2028) & (USD/Kg)
Figure 13. Global Diabetic Therapeutic Drugs Production Capacity (2017-2028) & (MT)
Figure 14. Global Diabetic Therapeutic Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Diabetic Therapeutic Drugs Market Drivers
Figure 16. Diabetic Therapeutic Drugs Market Restraints
Figure 17. Diabetic Therapeutic Drugs Market Trends
Figure 18. Global Diabetic Therapeutic Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Diabetic Therapeutic Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Diabetic Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Diabetic Therapeutic Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Diabetic Therapeutic Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Diabetic Therapeutic Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Diabetic Therapeutic Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Diabetic Therapeutic Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Diabetic Therapeutic Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Diabetic Therapeutic Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Diabetic Therapeutic Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Diabetic Therapeutic Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Diabetic Therapeutic Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Diabetic Therapeutic Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Diabetic Therapeutic Drugs Price by Type (2017-2028) & (USD/Kg)
Figure 33. Global Diabetic Therapeutic Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Diabetic Therapeutic Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Diabetic Therapeutic Drugs Price by Application (2017-2028) & (USD/Kg)
Figure 36. North America Diabetic Therapeutic Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Diabetic Therapeutic Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Diabetic Therapeutic Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Diabetic Therapeutic Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Diabetic Therapeutic Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Diabetic Therapeutic Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Diabetic Therapeutic Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Diabetic Therapeutic Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Diabetic Therapeutic Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Diabetic Therapeutic Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Diabetic Therapeutic Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Diabetic Therapeutic Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Diabetic Therapeutic Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Diabetic Therapeutic Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Diabetic Therapeutic Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Diabetic Therapeutic Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Diabetic Therapeutic Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Diabetic Therapeutic Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Diabetic Therapeutic Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Diabetic Therapeutic Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Diabetic Therapeutic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Diabetic Therapeutic Drugs in 2021
Figure 77. Manufacturing Process Analysis of Diabetic Therapeutic Drugs
Figure 78. Diabetic Therapeutic Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 糖尿病用ペンキャップのグローバル市場展望 2023年-2029年：スマート型、一般型
  • 世界の糖尿病検査ストリップ市場2022年：市場規模予測（～2028年）
  • 世界の糖尿病性眼疾患用デバイス市場2022年：市場規模予測（～2028年）
  • 糖尿病用ランセット装置のグローバル市場展望 2023年-2029年：50テストストリップ、100テストストリップ、150テストストリップ、200テストストリップ
  • 世界の糖尿病用インスリンクーラー市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19262 )"世界の糖尿病治療薬市場2022年：市場規模予測（～2028年）" (英文：Global Diabetic Therapeutic Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。